Page last updated: 2024-08-16

ribavirin and Diabetes Mellitus, Type 2

ribavirin has been researched along with Diabetes Mellitus, Type 2 in 21 studies

Research

Studies (21)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (33.33)	29.6817
2010's	13 (61.90)	24.3611
2020's	1 (4.76)	2.80

Authors

Authors	Studies
Abdel Alem, S; Abdellatif, Z; Abdo, M; Moustafa, A; Rabiee, A	1
Berry, K; Chang, M; Green, PK; Hettinger, BD; Hum, J; Ioannou, GN; Jou, JH; Lundblad, J	1
Abdel Alem, S; Abdellatif, Z; Adel, E; Elsharkawy, A; Esmat, G; Fouad, R; Hussein, MS; Musa, S; Nagy, A; Yosry, A	1
Bansal, M; Bichoupan, K; Branch, AD; Crismale, JF; Dieterich, DT; Liu, LU; Martel-Laferrière, V; Odin, JA; Pappas, A; Perumalswami, PV; Schiano, TD; Schonfeld, E; Wyatt, C	1
Andriulli, A; Angelico, M; Di Marco, V; Fasano, M; Fattovich, G; Felder, M; Gaeta, GB; Gatti, P; Granata, R; Ippolito, AM; Mazzella, G; Milella, M; Morisco, F; Santantonio, T; Smedile, A; Valvano, MR	1
Cooper, C; Doyle, MA	1
Bo, Q; Brass, C; Griffel, L; Orsenigo, R; Wang, J	1
Abate, ML; Bo, S; Bugianesi, E; Cassader, M; Ciancio, A; Ciccone, G; Gambino, R; Giordanino, C; Olivero, A; Pellicano, R; Rizzetto, M; Saracco, G; Smedile, A	1
Akuta, N; Arase, Y; Hirakawa, M; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Sezaki, H; Suzuki, F; Suzuki, Y; Yatsuji, H	1
Pandya, PK; Rao, GA	1
Hamzeh, FM; Han, J; Harrison, SA; Pandya, PK; Sheikh, MY; Vierling, JM	1
Abbott, D; Lee, HK; Trask, LE	1
Petta, S	1
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kobayashi, T; Kumada, H; Saito, S; Sezaki, H; Suzuki, F; Suzuki, Y	1
Tai, YK; Tsai, CY; Wu, CS	1
Chuang, WL; Dai, CY; Huang, JF; Yu, ML	1
Fukunaga, K; Morita, M; Murao, S; Nishumi, T; Shibutani, Y; Tani, S; Uchikoga, O; Yagi, N	1
Bowler, L; Coates, P; Singh, P; Tahrani, A	1
Godoy Guerrero, M; Manteca González, R; Palacios Rodríguez, S; Salgado Ordóñez, F	1
Alonso, S; Andrade, RJ; Barcena, R; Carmona, I; Diago, M; Durán, S; Fernández-Rodríguez, CM; Perez, R; Planas, R; Pons, JA; Romero-Gómez, M; Salmerón, J; Solá, R	1
Agud, JM; Apraiz, L; Portu, J; Tarabini-Castellani, P	1

Reviews

2 review(s) available for ribavirin and Diabetes Mellitus, Type 2

Article	Year
Glucose abnormalities in hepatitis C virus infection. The Kaohsiung journal of medical sciences, 2013, Volume: 29, Issue:2 Topics: Adult; Antiviral Agents; Diabetes Mellitus, Type 2; Disease Progression; Female; Glucose; Hepacivirus; Hepatitis C, Chronic; Humans; Insulin; Insulin Resistance; Interferon-alpha; Male; Middle Aged; Ribavirin	2013
Resolution of diabetes in type 2 diabetic patient treated with IFN-alpha and ribavirin for hepatitis C. European journal of gastroenterology & hepatology, 2006, Volume: 18, Issue:3 Topics: Adult; Antiviral Agents; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Remission Induction; Ribavirin; Treatment Failure; Weight Loss	2006

Trials

2 trial(s) available for ribavirin and Diabetes Mellitus, Type 2

Article	Year
Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study. The American journal of gastroenterology, 2008, Volume: 103, Issue:10 Topics: Adult; Antiviral Agents; Blood Glucose; Diabetes Mellitus, Type 2; Drug Carriers; Female; Follow-Up Studies; Glucose Intolerance; Glucose Tolerance Test; Hepacivirus; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Incidence; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Italy; Male; Middle Aged; Polyethylene Glycols; Polymerase Chain Reaction; Prognosis; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; RNA, Viral; Time Factors	2008
Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin. Hepatology (Baltimore, Md.), 2012, Volume: 56, Issue:2 Topics: Adult; Antiviral Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Hypoglycemic Agents; Insulin Resistance; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Pioglitazone; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Thiazolidinediones; Treatment Outcome	2012

Article

Year

Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.

The American journal of gastroenterology, 2008, Volume: 103, Issue:10

Topics: Adult; Antiviral Agents; Blood Glucose; Diabetes Mellitus, Type 2; Drug Carriers; Female; Follow-Up Studies; Glucose Intolerance; Glucose Tolerance Test; Hepacivirus; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Incidence; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Italy; Male; Middle Aged; Polyethylene Glycols; Polymerase Chain Reaction; Prognosis; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; RNA, Viral; Time Factors

2008

Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin.

Hepatology (Baltimore, Md.), 2012, Volume: 56, Issue:2

Topics: Adult; Antiviral Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Hypoglycemic Agents; Insulin Resistance; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Pioglitazone; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Thiazolidinediones; Treatment Outcome

2012

Other Studies

17 other study(ies) available for ribavirin and Diabetes Mellitus, Type 2

Article	Year
Impact of sustained virological response on metabolic disorders in diabetic chronic hepatitis C virus patients after treatment with generic sofosbuvir and daclatasvir. European journal of gastroenterology & hepatology, 2021, 12-01, Volume: 33, Issue:12 Topics: Antiviral Agents; Carbamates; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Pyrrolidines; Retrospective Studies; Ribavirin; Sofosbuvir; Treatment Outcome; Valine	2021
Improvement in Glycemic Control of Type 2 Diabetes After Successful Treatment of Hepatitis C Virus. Diabetes care, 2017, Volume: 40, Issue:9 Topics: Aged; Antiviral Agents; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Hepatitis C, Chronic; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Ribavirin; Sustained Virologic Response	2017
Improvement of glycemic state among responders to Sofosbuvir-based treatment regimens: Single center experience. Journal of medical virology, 2017, Volume: 89, Issue:12 Topics: Aged; Antiviral Agents; Blood Glucose; Diabetes Mellitus, Type 2; Egypt; Female; Glycated Hemoglobin; Glycemic Index; Hepacivirus; Hepatitis C, Chronic; Humans; Insulin Resistance; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Ribavirin; Sofosbuvir	2017
Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34, Issue:7 Topics: Anemia; Diabetes Mellitus, Type 2; Hepatitis C; Humans; Interferon-alpha; Liver Cirrhosis; Logistic Models; Multivariate Analysis; Odds Ratio; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Statistics, Nonparametric	2014
HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome. Hepatology international, 2015, Volume: 9, Issue:1 Topics: Adult; Age Factors; Antiviral Agents; Diabetes Mellitus, Type 2; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Sex Factors; Treatment Outcome	2015
Successful Hepatitis C Antiviral Therapy Induces Remission of Type 2 Diabetes: A Case Report. The American journal of case reports, 2015, Oct-20, Volume: 16 Topics: Antiviral Agents; Diabetes Mellitus, Type 2; Hepatitis C, Chronic; Humans; Male; Middle Aged; Remission Induction; Ribavirin	2015
Glucose abnormalities in Asian patients with chronic hepatitis C. Drug design, development and therapy, 2015, Volume: 9 Topics: Adult; Age Factors; Antiviral Agents; Asian People; Blood Glucose; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclosporine; Diabetes Mellitus, Type 2; Female; Hepatitis C, Chronic; Humans; Interferons; Logistic Models; Male; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Ribavirin; Risk Factors; Sex Factors; Treatment Outcome	2015
Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:3 Topics: Adult; Antiviral Agents; Cohort Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; RNA, Viral	2009
Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C. Gastroenterology, 2011, Volume: 140, Issue:1 Topics: Antiviral Agents; Cohort Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Insulin; Interferon alpha-2; Interferon-alpha; Longitudinal Studies; Male; Metformin; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load	2011
Low hemoglobin A(1c)--good diabetic control? Clinical chemistry, 2012, Volume: 58, Issue:3 Topics: Anemia; Diabetes Mellitus, Type 2; Erythropoietin; Female; Glycated Hemoglobin; Hepatitis C; Humans; Insulin Glargine; Insulin, Long-Acting; Interferon-alpha; Metformin; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2012
Insulin resistance and diabetes mellitus in patients with chronic hepatitis C: spectators or actors? Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2012, Volume: 44, Issue:5 Topics: Antiviral Agents; Diabetes Mellitus, Type 2; Female; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2012
Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C. Hepatology (Baltimore, Md.), 2013, Volume: 57, Issue:3 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Incidence; Interferons; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Ribavirin; Risk Factors	2013
Combination effect of ribavirin and erythropoietin treatment on hemoglobin A1c in a diabetic patient with chronic hepatitis C. Journal of the Chinese Medical Association : JCMA, 2012, Volume: 75, Issue:10 Topics: Diabetes Complications; Diabetes Mellitus, Type 2; Drug Synergism; Drug Therapy, Combination; Erythropoietin; Female; Glycated Hemoglobin; Hepatitis C, Chronic; Humans; Middle Aged; Ribavirin	2012
[Type 2 diabetes mellitus with histological finding of nonalcoholic steatohepatitis following combination therapy with interferon and ribavirin for chronic hepatitis C]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2005, Volume: 102, Issue:8 Topics: Adult; Antiviral Agents; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Fatty Liver; Hepatitis C, Chronic; Humans; Interferons; Male; Ribavirin	2005
[Patient with HCV chronic hepatitis who has subcutaneous nodules after finishing treatment with pegylated interferon]. Revista clinica espanola, 2005, Volume: 205, Issue:12 Topics: Antiviral Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Hypertension; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sarcoidosis	2005
Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C. Journal of hepatology, 2008, Volume: 48, Issue:5 Topics: Adult; Alanine Transaminase; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Ribavirin; Viral Load	2008
[Diabetes mellitus during interferon therapy]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26, Issue:2 Topics: Adult; Anti-HIV Agents; Antiviral Agents; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2008